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Comparison of the WY-4 and HIV-2 proteinases using oligageptide 
substrates representing cleavage sites in Gag and C&glPol polyproteins 
The xutrx~r~ spa5tkity af rho humn inmunodclicicncy vitua gyp I (HIV-I) unci ~ypc’ 2 (HIV-2) pruteimscr ww cumpsrrcl uxiny oli~sprptidcx 
carreqxMin@ to ckrtveyc aitcx in tha Gqt und Gug4W palyprutcias ur both viruses. All p6lxidcI mimickinp clcavtiyo ailcr MI the junction QT major 
functiunul pratcin danr;rins were correctly elctivcd by both cnxymcs. Hawuvrr, some athcr peptidcs thought tm reprrwcnt rrcandary cle~ugl: sites 
rcmiiierd intact. ‘Ptrc kin& p:trcttnctcrx (A’* end k,,) abrainrd far the difikranc atbstrstu rhuwal wcvcrd hunJrc&fultl variation but were rimibr 
for the MTIC subrtrutc. 
1. INTRODUCTION 
The retroviral proteinase (PR) is responsible for 
specific cleavages of the Gag and Gag-P01 polypro- 
teins. Because of its crucial role in virus maturation and 
infectivity, the PR of both HIV-1 and HIV-2 is a poten- 
tial target for chemotherapy of virus infection and 
associated iseases [ 11. 
The characterization of retroviral cleavage sites re- 
quires the isolation of the viral protein products, the 
determination of their N- and C-terminal sequences, 
and comparison of these sequences to the nucleotide se- 
quence, as has been done in our laboratory for a 
number of rctroviruses [2] including HIV-l [3] and si- 
mian immunodeficiency virus (SIVhanc) [4], Similar 
studies were not done to determine the cleavage sites in 
the HIV-2 Gag and Gag-PO1 polyproteins, they were 
predicted on the basis of homology with SIVM,,, and 
HIV-l [4-61. Twelve naturally occurring cleavage sites 
have been determined in HIV-1 Gag and Gag-PO1 
polyproteins [3,5-g]. A series of selected oligopeptides 
representing cleavage sites were tested and found to be 
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cleaved by HIV-1 PR [IQ]. Similar extensive studies 
have not been performed for HIV-2 cleavage sites, 
Our aim was to investigate the substrate specificity of 
HIV-1 and HIV-2 PRs by the determination of the 
kinetic parameters for the cleavage of oligopcptides 
representing all determined and/or predicted cleavage 
sites of the HIV-l and HIV-2 Gag and Gag-PO1 precur- 
sor polyproteins. Kinetic characterization of the PR is 
important for understanding its biology and is useful 
for inhibitor design. 
2. M,4TERIALS AND METHODS 
Recombinant HIV-I PR [I I] and chemically synthesized HIV-2 PR 
(6,121 wcrc used. Active enzyme content was detcrmincd by active site 
titration using a potent transition-state analog inhibitor [13]. 
Oligopeptides having amide C terminus were synthesized and 
characterized by amino acid analysis and sequencing as described [6]. 
Peptidcs containing the !&CI-IzNI-I] pseudopeptidc bond were syn- 
thesized according to Sasaki et al. [14]. 
Protcinase assays were performed in 0,25 M potassium phosphate 
buffer, pH 5.6, containing 7.5% glycerol, 5 mM dithiothreitol, 
I mM EDTA, 0.2% Nonidct P-40 and 2 M NaCI. The reaction mix- 
ture was incubated at 37°C for t h and stopped by the addition of 
guanidine-HCI (6 M final concentration). The cleavage products 
were detected by reversed-phase HPLC [6], the product peaks were 
integrated, and the kinetic parameters were determined at less than 
20% substrate turnover by fitting the data to the Michaelis-Menten 
equation using the Gauss-Newton iteration method. The computer 
program (Edz 5.0) was written and kindly provided by M. Fivash and 
J. Racheff of the Data Management Services, Inc., NCI-FCRDC, 
Frederick. The asymptotic standard errors were S-20%. For two 
peptides the proper I&, value could not be determinedi for these psp- 
tides the kcn,/Kn, values were determined using competition assays 
[IS]. Inhibitor constants were determined according to Dixon [16]. 
The estimated error of all determinations was below 20%. 
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3. RESULTS AND DISCUSSION 
Oligopeptidcs representing determined cleavage sites 
in HIV-l GQ and Gag-P01 polyproteins and predicted 
cleavage sites in I-W-2 Gag and Gag-Pol polyproteins 
(Fig. I) were tested as substrates for both HIV-l and 
HIV-2 PRs (Tables I and II), All of the oligopeptidcs 
representing cleavage sites at the junction of major 
functional protein domains (see Fig. 1) of HIV-l (Table 
I) as well as of HIV-2 (Table II) were cleaved at the 
predicted sites in both homologous and heterologous 
systems. Peptides representing cleavage sites in p6 of 
I-W-1 (peptidc viii) and in RT of both viruses (pcptidcs 
xi and xx) were also found to be hydrolyzed by both en- 
zymcs. The specificity of the cleavage of oligopeptide 
substrates representing the major cleavage sites in 
HIV-2 polyprotcins by the purified enzymes further 
suggests that they were predicted correctly. However, 
pepcides mimicking another cleavage site in p6 and a 
cleavage site in X of HIVWl als well as in the NC domain 
of both viruses (peptides vii, iii, v and xvi respectively, 
see Fig. 1, and Tables I and II) were not hydrolyzed by 
either of the erlzymes even after 24-h incubation at 
37OC. These noncleaved peptides contain a small, non- 
hydrophobic residue at either the PI or PI’ position 
(notation according to Schcchter and Berger, [17]). If 
these cleavages in the Gag polyproteins are performed 
by the viral enzyme, additional sequential and/or con- 
formational factors may be necessary for this process- 
ing. The presence of hydrophobic side chains at PI and 
PI’ positions are known to be preferred for efficient 
proteolytic activity of HIV PRs. 
‘l-able I 
Kinetic paramctcrs obtained for HIV-I and HIV-2 PR using oligopcptides representing the cleavage sites in HIV-I Gag and Gag-Pal polyprotcins 
Peptide Location 
of 
dCWilg~ 
Sequence HIV-I PR HIV-2 PR 
EC,,\ kc,, hWA’I1, K,,, ko, k&K,,, 
(mM) (SW’) (rhM-’ *s-I) (mM) (s”‘) (mM”‘~s-‘) 
i. 
ii. ..* 
III. 
iv. 
V. 
vi. 
vii. 
*,* 
VIII. 
ix. 
X. 
xi. 
xii. 
MA/CA VSQNY PIVQ’ 
CA/X KARVL AEAMS 
ia X VLAEAMsSQVTN” 
X/NC TATIM,:MQRGN 
in NC TERQANoFLGKI 
NC/p6 RPQNF<;LQSRP’ 
in p6 ESFRSGeVETTT 
in p6 DKELYcPLTSL 
TF/PK VSFNFoPQITL 
PR/RT CTLNF*>PlSP 
in RT AETFcYVDGAA 
RT/I N IRKILc>FLDG 
0.15 6.8 
0.01 0.09 
not hydrolyzed 
3.1 0,05 
0.53 
0.41 
to.01 
0.07 
0.04 
0.006 
not hydrolyzed 
0.3 
not hydrolyzed 
0.01 
0.06 
1.5 
0.4 
1.2 
45.3 0.18 
90.0 0.03 
74.0 0,08 
0.6 0.30 
0.02 0,42 
6.9d co.01 
24.1 0.06 
10.0 0.17 
202.0 0.005 
6.2 34.4 
0,9 30.0 
not hydrolyzed 
3,s 43,x 
not hydrolyzed 
0,2 0.7 
not hydrolyzed 
0.09 0.21 
0.06 6.2” 
0.4 6.7 
1.0 5.8 
1.2 240.0 
” Cleavage sites proved by amino acid analysis are marked with open circles in the substrate sequences 
b These peptides were subjected to a 24-h incubation with the enzymes. Cleavage sites found by sequence analysis but not hydrolyzed in the 
oligopeptide are marked with solid circles 
’ Sequence from protein sequencing [3]. Deducted from the nucleoticle sequence [29], there is Gly at the PS position. RPGNF: LQSRP was also 
investigated, and the kinetic parameters for its hydrolysis were found to be very similar to that of peptide vi 
’ Measured with competition assay [15] with the MA/CA cleavage site (pcptide i) 
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Kinetic Rarclmeters for the substrates were determin- 
cd using bbth HIV-1 and HIV-2 PR at high (2 M) oelt 
concentration (Tables I and II). As for the avian cn- 
zymc [18], this high ionic strength was found to be op- 
timal for NIV Pl2s (our unpublished result). The K,,, 
values were found to be in the micromolar ran&! 
(S-1250 rM) showing an approximate 300.fold varia- 
tion, while the L,, values differed at least 600-fold 
(0.01-6.8 s-l) considering both the homologous and 
hetcrologous ystems. The kinetic parameters for the 
two PRs showed remarkable similarities, The kinetic 
parameters for the hydrolysis of some oligopeptidcs 
were found to be similar also by others [19,20]. Fur- 
thermore, the interchange of the PR domain of the pal 
genes of HIV-1 and HIV-2 resulted in complete, though 
less efficient, autocatalysis of the chimeric polyproteins 
in an E. cd expression system [S]. The HIV-l and 
HIV-2 PRs show a 70070 homology [6]. Comparing the 
side chains of I-IIV-I PR involved in the 
enzyme-substrate interaction in the SJ-SJ’ positions 
[21] to the respective side chains in HIV-2 PR, one 
finds only conservative changes (two Val-Ile exchanges 
and an Ilc-Val exchange). The strong homology in the 
S3-S3 ’ region may explain the similar kinetic constants 
obtained for both enzymes. However, some differences 
were also found, regarding both the K,,, and the k,,, 
Table 111 
Inhibitory constarits obtained by peptides containing reduced bond 
Peptide Ki b&M)” 
- 
HIV-1 PR HIV-2 PR 
@-ix VSFNF(lk)PQITL 0,030 0.025 
‘IJ-x CTLNF(lk)PISP 0,7 0.6 
a Using peptide i as substrate, the Ki value was determined according 
to Dixon [16], in the presence of 2 M NaCI. Both inhibitions were 
of the competitive type 
values (Tables I and II). Recently Tomasseli et al, [20] 
have reported, that while a peptidc with X/NC cleavage 
site sequence (Ps-P,‘) of HIV-2 was hydrolyzed only 
by HIV-2 PR, another pcptidc with NC/p6 sequence 
(Ps-PJ’) of HIV-2 was not hydrolyzed by either of the 
enzymes, On the contrary, the related but longer pcp- 
tides (Ps-Ps’) in our series were hydrolyzed by both en- 
zymes (see Table II). The apparent discrepancies may 
be due to the difference in the lengths of the pcptides 
and/or to different assay conditions. 
A classification of the cleavage sites found in HIV-1 
and SIV as well as predicted for HIV-2 Gag and Gag- 
Pal polyproteins has been published from our 
laboratory, based on the scissile bonds and the surroun- 
ding sequences [4]. While some of the peptides 
representing Class 2 or Class 3 cleavage sites were not 
hydrolyzed, all of the peptides representing Class 1 
cleavage sites were hydrolyzed by HIV PRs. However, 
a strong relationship between the classification and the 
kinetic data of the substrate hydrolysis was not found. 
For example, the two peptides, one with the highest and 
the other with the lowest catalytic constant in the 
HIV-1 homologous eries (peptide i and viii respective- 
ly) belong to Class 1, characterized by the 
Tyr(Phe)/Pro scissile bond. Furthermore, the kinetic 
parameters for peptide ix and x are also substantially 
different, although both have an -Asn-Phe/Pro- se- 
quence at the cleavage site. These findings suggest, hat 
amino acids relatively far from the cleavage site may 
significantly contribute to the binding and activation 
energies, as was found by substitution of amino acids 
at P4-Pz positions [19,22]. 
Two substrates (ix and x in Table I) containing the 
highly specific Phe/Pro cleavage site were selected to 
synthesize their pseudopeptide analog containing a 
P[CHzNH] bond. The analogs were found to be com- 
petitive inhibitors of both HIV PRs (Table III). Their 
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